China SXT Pharmaceuticals (SXTC) Operating Leases (2023 - 2025)
Historic Operating Leases for China SXT Pharmaceuticals (SXTC) over the last 3 years, with Q1 2025 value amounting to $176648.0.
- China SXT Pharmaceuticals' Operating Leases fell 2510.09% to $176648.0 in Q1 2025 from the same period last year, while for Mar 2025 it was $176648.0, marking a year-over-year decrease of 2510.09%. This contributed to the annual value of $176648.0 for FY2025, which is 2510.09% down from last year.
- As of Q1 2025, China SXT Pharmaceuticals' Operating Leases stood at $176648.0, which was down 2510.09% from $235848.0 recorded in Q1 2024.
- In the past 5 years, China SXT Pharmaceuticals' Operating Leases registered a high of $306050.0 during Q1 2023, and its lowest value of $176648.0 during Q1 2025.
- Moreover, its 3-year median value for Operating Leases was $235848.0 (2024), whereas its average is $239515.3.
- As far as peak fluctuations go, China SXT Pharmaceuticals' Operating Leases tumbled by 2293.81% in 2024, and later crashed by 2510.09% in 2025.
- Over the past 3 years, China SXT Pharmaceuticals' Operating Leases (Quarter) stood at $306050.0 in 2023, then fell by 22.94% to $235848.0 in 2024, then dropped by 25.1% to $176648.0 in 2025.
- Its Operating Leases was $176648.0 in Q1 2025, compared to $235848.0 in Q1 2024 and $306050.0 in Q1 2023.